A61L 2300/42
Anti-thrombotic agents, anticoagulants, anti-platelet agents
A61L2300/42 (Anti-thrombotic agents, anticoagulants, anti-platelet agents) appears on 591 US grants and 808 published applications in this corpus.
Search patents in A61L- Granted patents
- 591
- Published applications
- 808
- Assignees
- 378
- Inventors
- 1,383
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 10 | 0 |
| 1995 | 9 | 0 |
| 1996 | 10 | 0 |
| 1997 | 10 | 0 |
| 1998 | 19 | 0 |
| 1999 | 9 | 0 |
| 2000 | 13 | 0 |
| 2001 | 15 | 5 |
| 2002 | 15 | 20 |
| 2003 | 11 | 22 |
| 2004 | 8 | 29 |
| 2005 | 9 | 35 |
| 2006 | 8 | 38 |
| 2007 | 8 | 42 |
| 2008 | 15 | 30 |
| 2009 | 9 | 34 |
| 2010 | 18 | 41 |
| 2011 | 9 | 23 |
| 2012 | 16 | 32 |
| 2013 | 15 | 16 |
| 2014 | 29 | 29 |
| 2015 | 25 | 45 |
| 2016 | 37 | 52 |
| 2017 | 32 | 44 |
| 2018 | 25 | 50 |
| 2019 | 21 | 33 |
| 2020 | 29 | 39 |
| 2021 | 23 | 37 |
| 2022 | 20 | 27 |
| 2023 | 24 | 27 |
| 2024 | 26 | 29 |
| 2025 | 23 | 17 |
| 2026 | 9 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Generating endothelial cell-seeded vascular grafts22 Sep 2026US 12,741,060 B2Wisconsin Alumni Research Foundation
- Tissue-plasminogen activator coated catheter with hydrogel-controlled elution8 Sep 2026US 12,728,185 B2Becton, Dickinson and Company
- Ionic polymers for medical device applications30 Jun 2026US 12,667,645 B2Becton, Dickinson and Company
- Coating for medical devices14 Apr 2026US 12,599,707 B2Smart Reactors Service Limited
- Ionic compounds for medical device applications7 Apr 2026US 12,594,365 B2Becton, Dickinson and Company
- Heparin-functionalized surface, method for its preparation and use thereof20 Aug 2026US 2026/0241080 A1
- High strength biomedical materials6 Aug 2026US 2026/0224782 A1Access Vascular, Inc.
- Method of preventing blood coagulation and drug-eluting implant for percutaneous coronary intervention16 Jul 2026US 2026/0199564 A1
- Drug coated balloon11 Jun 2026US 2026/0158194 A1Arterius Limited
- Instrument for use in blood vessel, and coating agent4 Jun 2026US 2026/0151544 A1Japan Medical Device Startup Incubation Program
Most cited
By later US patents
- Drug releasing anastomosis devices and methods for treating anastomotic sites1,779US 7,108,701 B2Ethicon, Inc. · 2006
- Surgical implant and method for controlled release of chemotherapeutic agents1,679US 5,290,271 A1994
- Vascular closure device1,319US 8,790,684 B2Cordis Corporation · 2014
- Coated implantable medical device1,180US 6,096,070 ACook Incorporated · 2000
- Intravascular stent and method1,050US 5,464,650 AMedtronic, Inc. · 1995